tiprankstipranks
Advertisement
Advertisement

IMTX Stock Latest News

Immatics assumed with a Buy at Jefferies
The FlyImmatics assumed with a Buy at Jefferies
25d ago
IMTX
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
PremiumCompany Announcements
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
1M ago
6K
IMTX
Immatics sees cash runway into 2028
PremiumThe Fly
Immatics sees cash runway into 2028
1M ago
IMTX
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
PremiumThe Fly
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
1M ago
IMTX
Immatics price target raised to $25 from $23 at Mizuho
PremiumThe Fly
Immatics price target raised to $25 from $23 at Mizuho
2M ago
IMTX
Immatics’ treatment of Stage II and higher CM granted FDA orphan designation
PremiumThe FlyImmatics’ treatment of Stage II and higher CM granted FDA orphan designation
2M ago
IMTX
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
Premium
Company Announcements
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
3M ago
6K
IMTX
Immatics price target raised to $17 from $14 at BofA
Premium
The Fly
Immatics price target raised to $17 from $14 at BofA
3M ago
IMTX
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
PremiumCompany Announcements
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
4M ago
6K
IMTX
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
PremiumThe Fly
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
4M ago
IMTX
Immatics Completes $116.5 Million Share Offering to Boost R&D
PremiumCompany Announcements
Immatics Completes $116.5 Million Share Offering to Boost R&D
4M ago
6K
IMTX
Immatics announces offering of 12.5M ordinary shares
PremiumThe Fly
Immatics announces offering of 12.5M ordinary shares
4M ago
IMTX
Immatics N.V. Reports Q3 2025 Financial Results and Progress
PremiumCompany AnnouncementsImmatics N.V. Reports Q3 2025 Financial Results and Progress
5M ago
IMTX
Immatics price target raised to $23 from $19 at Mizuho
Premium
The Fly
Immatics price target raised to $23 from $19 at Mizuho
5M ago
IMTX
Immatics price target raised to $19 from $16 at Guggenheim
Premium
The Fly
Immatics price target raised to $19 from $16 at Guggenheim
5M ago
IMTX
Morning Movers: E.W. Scripps surges after report of Sinclair takeover interest
PremiumThe Fly
Morning Movers: E.W. Scripps surges after report of Sinclair takeover interest
5M ago
SEE
SSP
Immatics Reports Q3 2025 Financial Results and Business Update
PremiumCompany Announcements
Immatics Reports Q3 2025 Financial Results and Business Update
5M ago
6K
IMTX
Immatics reports Q3 EPS (EUR 0.42) vs (EUR 0.08) vs last year
PremiumThe Fly
Immatics reports Q3 EPS (EUR 0.42) vs (EUR 0.08) vs last year
5M ago
IMTX
IMTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IMTX Earnings this Week: How Will it Perform?
5M ago
IMTX
Promising Efficacy and Safety of Immatics’ IMA402 and IMA401 Drive Buy Rating
PremiumRatingsPromising Efficacy and Safety of Immatics’ IMA402 and IMA401 Drive Buy Rating
5M ago
IMTX
Immatics Reveals Promising Phase 1a Results for TCR Bispecifics
Premium
Company Announcements
Immatics Reveals Promising Phase 1a Results for TCR Bispecifics
5M ago
6K
IMTX
Immatics announces updated Phase 1a dose escalation data for IMA402, IMA401
Premium
The Fly
Immatics announces updated Phase 1a dose escalation data for IMA402, IMA401
5M ago
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >